386
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients

, , &
Pages 260-267 | Received 15 Apr 2010, Accepted 28 Jun 2010, Published online: 12 Aug 2010

References

  • Mishra DN, Bindal M, Singh SK, Kumar SGV. (2006). Spray dried excipient base: A novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull, 54(1):99–102.
  • Shu T, Suzuki H, Hironaka K, Ito K. (2002). Studies of rapidly disintegrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull, 50(2):193–8.
  • Bogner RH, Wilkosz MF. Fast dissolving tablets. http://www. uspharmacist.com [accessed May 20, 2010].
  • Bolhuis GK, Rexwinkel EG, Zuurman K. (2009). Polyols as fillers-binders for disintegrating tablets prepared by direct compaction. Drug Dev Ind Pharm, 35(6):671–7.
  • Chang RK, Guo X, Couch RA. (2000). Fast dissolving tablets. Pharm.Technol, 6:52–8.
  • Seager H. (1998). Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol, 50:375–82.
  • Habib W, Khankari RK, Hontz J. (2000) Fast dissolve drug delivery systems. Crit Rev Ther Drug Carrier Sys, 17:61–72.
  • Jacob S, Shirwaikar A, Nair A. (2009). Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide. Drug Dev Ind Pharm, 35(3):321–8.
  • Sunada H, Bi Y. (2002). Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol, 122:188–98.
  • Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, Mockoviak SH, . (2002). Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: A randomized, placebo-controlled clinical trial. Clin Ther 24(4):490–503.
  • McNeely W, Goa KL. (1999). Diclofenac-potassium in migraine: A review. Drugs, 57(6):991–1003.
  • Diener HC, Montagna GG, Lyczak P, Schumann G, Zöller B, Mulder LJMM, . (2005). Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia, 26:537–47.
  • Silberstein SD, Freitag FG. (2003). Preventive treatment of migraine. Neurology 60(7) Suppl.2:38–44.
  • Bucci R, Magrì AD, Magrì AL. (1998). Determination of diclofenac salts in pharmaceutical formulations. Fresenius J Anal Chem, 362:577–82.
  • ICH Guideline (1996). Validation of analytical procedures: Text and methodology Q2 (R1).
  • Bi YX, Sunada Y, Yonezawa Y, Danjo K. (1999). Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm, 25(5):571–81.
  • Comoglu T, Gönül N. (2005). Quality control studies on conventional carbamazepine tablets that are available in Turkish drug market. Turk J Med Sci, 35:217–21.
  • Klancke J. (2003). Dissolution testing of orally disintegrating tablets. Dissolution Technologies, May: 6–8.
  • Kimura S, Imai T, Ueno M, Otagiri M. (1992). Pharmaceutical evaluation of ibuprofen fast absorbed syrup containing low-molecular weight gelatin. J Pharm Sci, 81:141–4.
  • Ishikawa T, Mukai B, Shiraishi S, Utoguchi N, Fujii M, Matsumoto M, . (2001). Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method. Chem Pharm Bull, 49(2):134–9.
  • Kubitzek F, Ziegler G, Gold MS, Liu JMH, Ionescu E. (2003). Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain, 7:155–62.
  • Bolhius GK, Chowhan ZT. (1996). Materials for direct compression. In: Alderborn G, Nystrom C, eds. Pharmaceutical powder compaction technology. New York: Marcel Dekker Inc., 476–80.
  • Ilic I, Kasa JP, Dreu R, Hodi-Pintye K, Srcic S. (2009). The compressibility and compactibility of different types of lactose. Drug Dev Ind Pharm, 35(10):1271–80.
  • David ST, Augsberger LL. (1977). Plastic flow during compression of directly compressible fillers and its effect on tablet strength. J Pharm Sci 66:155.
  • Gohel MC, Jogani PD. (2005). A review of co-processed directly compressible excipients. J Pharm Pharmaceut Sci, 8(1):76–93, www.cspscanada.org [accessed May 20, 2010].
  • Rizzuto AB, Chen AC, Veign MF. (1984). Effect of moisture content on compression properties of two dextrose-based directly compressible diluents. Pharm Tech 8(9):32.
  • Shangraw R, Mitrejev A, Shah M. (1980). A new era of tablet disintegrants. Pharm Tech 4:49–57.
  • Mizumoto T, Yoshinori M, Yamamoto T, Yonemochi E, Terada K. (2005). Formulation design of a novel fast-disintegrating tablet. Int J Pharm 306: 83–90.
  • Webb PA. Volume and density determinations for particle technologists. Micromeritics Instrument Corp. 2001: p. 4. www. particletesting.com/docs/density_determinations.pdf [accessed May 20, 2010].
  • en.wiktionary.org/wiki/true_density [accessed May 20, 2010].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.